Literature DB >> 16088564

Drug-induced lung disease: a pragmatic classification incorporating HRCT appearances.

Jeffrey L Myers1, Andrew H Limper, Stephen J Swensen.   

Abstract

Drug-induced lung disease frequently poses a diagnostic challenge. Knowledge of common radiological patterns of lung involvement and corresponding histopathologic diagnoses can facilitate management of individual patients. We outline a framework for understanding radiological and histologic patterns of drug-induced lung disease. Diffuse forms of drug-induced lung disease include processes that mimic acute respiratory distress syndrome (ARDS) and diffuse alveolar hemorrhage. These patterns of drug-induced lung disease are especially common in patients receiving cytotoxic chemotherapeutic agents. Chronic forms of drug-induced lung disease include many of the interstitial pneumonias seen more commonly in patients with idiopathic disease. Bronchiolitis obliterans organizing pneumonia and eosinophilic pneumonia are nonspecific patterns of drug-induced lung disease that are radiologically and histologically indistinguishable from their idiopathic counterparts. In some patients organizing pneumonia and eosinophilic pneumonia mimic the radiological appearance of neoplastic disease.

Entities:  

Year:  2003        PMID: 16088564     DOI: 10.1055/s-2003-42379

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  7 in total

Review 1.  Organizing pneumonia: a kaleidoscope of concepts and morphologies.

Authors:  Benjamin J Roberton; David M Hansell
Journal:  Eur Radiol       Date:  2011-07-10       Impact factor: 5.315

2.  Ketorolac tromethamine associated with diffuse pulmonary haemorrhage: high-resolution CT findings.

Authors:  A Sperb Rubin; B Hochhegger; K L Irion; E Marchiori; S Rajeswari Binukrishnan; J S Moreira; G Zanetti
Journal:  Br J Radiol       Date:  2010-07       Impact factor: 3.039

Review 3.  Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.

Authors:  Osamu Matsuno
Journal:  Respir Res       Date:  2012-05-31

4.  Serum heat shock protein 47 levels in patients with drug-induced lung disease.

Authors:  Tomoyuki Kakugawa; Shin-ichi Yokota; Yuji Ishimatsu; Tomayoshi Hayashi; Shota Nakashima; Shintaro Hara; Noriho Sakamoto; Yasuhiro Matsuoka; Hiroshi Kubota; Mariko Mine; Hiroshi Mukae; Kazuhiro Nagata; Shigeru Kohno
Journal:  Respir Res       Date:  2013-11-20

5.  Relapsing pneumonitis due to two distinct inhibitors of the MAPK/ERK pathway: report of a case.

Authors:  Violaine Giraud; Christine Longvert; Solène Houlle-Crepin; Claire Danel; Sylvie Labrune; Philippe Camus; Philippe Saiag; Thierry Chinet
Journal:  BMC Cancer       Date:  2015-10-19       Impact factor: 4.430

Review 6.  Diagnosis and management of drug-associated interstitial lung disease.

Authors:  N L Müller; D A White; H Jiang; A Gemma
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

Review 7.  Pathological interpretation of connective tissue disease-associated lung diseases.

Authors:  Kun Young Kwon
Journal:  Yeungnam Univ J Med       Date:  2019-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.